🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 17 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/05/2000 | 49,36 | 49,59 | 46,32 | 46,79 | -5,21% | 6,64% | 48.624 |
| 12/05/2000 | 49,24 | 49,59 | 47,02 | 49,36 | +1,93% | 5,23% | 46.353 |
| 11/05/2000 | 46,32 | 49,59 | 45,85 | 48,42 | +6,15% | 8,08% | 70.532 |
| 10/05/2000 | 48,66 | 48,78 | 45,15 | 45,62 | -6,25% | 7,45% | 95.779 |
| 09/05/2000 | 50,06 | 50,53 | 48,66 | 48,66 | -3,26% | 3,74% | 27.865 |
| 08/05/2000 | 49,59 | 52,87 | 49,13 | 50,30 | -1,83% | 7,55% | 34.625 |
| 05/05/2000 | 54,51 | 54,74 | 51,23 | 51,23 | -6,01% | 6,44% | 25.461 |
| 04/05/2000 | 51,58 | 54,74 | 51,47 | 54,51 | +5,91% | 6,35% | 53.193 |
| 03/05/2000 | 50,76 | 52,40 | 50,53 | 51,47 | +1,85% | 3,69% | 54.983 |
| 02/05/2000 | 53,10 | 54,04 | 50,53 | 50,53 | -6,09% | 6,61% | 59.204 |
| 01/05/2000 | 51,00 | 54,27 | 50,53 | 53,81 | +9,00% | 7,34% | 92.360 |
| 28/04/2000 | 45,38 | 50,76 | 45,15 | 49,36 | +8,76% | 12,37% | 67.860 |
| 27/04/2000 | 46,09 | 47,72 | 44,45 | 45,38 | -3,96% | 7,11% | 50.281 |
| 26/04/2000 | 49,13 | 49,59 | 45,85 | 47,26 | -1,94% | 7,62% | 31.659 |
| 25/04/2000 | 49,24 | 50,06 | 46,55 | 48,19 | +1,98% | 7,13% | 39.006 |
| 24/04/2000 | 47,26 | 50,06 | 46,32 | 47,26 | -6,05% | 7,92% | 47.582 |
| 20/04/2000 | 49,36 | 52,17 | 48,66 | 50,30 | +1,42% | 7,11% | 49.052 |
| 19/04/2000 | 52,40 | 53,34 | 48,66 | 49,59 | -3,20% | 8,93% | 75.768 |
| 18/04/2000 | 45,85 | 52,17 | 44,92 | 51,23 | +11,73% | 15,82% | 104.703 |
| 17/04/2000 | 47,49 | 48,66 | 43,51 | 45,85 | -5,31% | 10,84% | 150.655 |
| 14/04/2000 | 52,40 | 53,34 | 47,72 | 48,42 | -11,54% | 10,71% | 236.309 |
| 13/04/2000 | 56,61 | 57,78 | 53,34 | 54,74 | -0,85% | 7,85% | 85.600 |
| 12/04/2000 | 59,89 | 61,29 | 55,21 | 55,21 | -7,81% | 10,16% | 56.506 |
| 11/04/2000 | 65,74 | 65,74 | 58,48 | 59,89 | -10,49% | 11,03% | 89.821 |
| 10/04/2000 | 69,01 | 69,71 | 65,50 | 66,91 | -3,38% | 6,10% | 138.927 |
| 07/04/2000 | 64,57 | 69,95 | 64,33 | 69,25 | +8,82% | 8,70% | 125.274 |
| 06/04/2000 | 62,69 | 66,67 | 62,23 | 63,63 | +3,03% | 7,09% | 71.120 |
| 05/04/2000 | 59,89 | 63,63 | 58,02 | 61,76 | -1,86% | 9,38% | 93.909 |
| 04/04/2000 | 62,69 | 63,63 | 49,59 | 62,93 | +1,89% | 22,39% | 185.307 |
| 03/04/2000 | 64,10 | 66,20 | 60,82 | 61,76 | -7,04% | 8,39% | 66.097 |